Oxford Immunotec

OXFD NASDAQ
12.72
-0.29
-2.23%
After Hours: 12.72 0 0.00% 16:00 07/23 EDT
Open
13.09
Prev Close
13.01
High
13.11
Low
12.69
Volume
81.50K
Avg Vol (3M)
221.31K
52 Week High
19.19
52 Week Low
11.66
% Turnover
0.31%
Market Cap
338.65M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Oxford Immunotec OXFD stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
MORE >

Recently

Name
Price
%Change